- Home
- AKRO vs NOVT Comparison
AKRO vs NOVT Comparison
Compare AKRO & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKRO | NOVT |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | AKRO | NOVT |
|---|---|---|
| Price | $54.65 | $118.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $73.56 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 2.4M | 455.5K |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | N/A | ★ $960,311,000.00 |
| Revenue This Year | N/A | $5.10 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | ★ N/A | $81.46 |
| Revenue Growth | N/A | ★ 4.07 |
| 52 Week Low | $21.34 | $98.27 |
| 52 Week High | $58.40 | $173.16 |
Technical Indicators
Market Signals| Indicator | AKRO | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 58.31 |
| Support Level | $54.30 | $114.19 |
| Resistance Level | $54.70 | $121.95 |
| Average True Range (ATR) | 0.17 | 3.36 |
| MACD | -0.10 | 1.17 |
| Stochastic Oscillator | 71.07 | 82.53 |
Price Performance
Historical ComparisonAbout AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.